This report contains market size and forecasts of Clinical Oncology Next Generation Sequencing in Global, including the following market information:
Global Clinical Oncology Next Generation Sequencing Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Clinical Oncology Next Generation Sequencing market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Clinical Oncology Next Generation Sequencing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Clinical Oncology Next Generation Sequencing Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Clinical Oncology Next Generation Sequencing Market Segment Percentages, By Type, 2020 (%)
Whole Genome Sequencing
Whole Exome Sequencing
Targeted Sequencing & Resequencing Centrifuges

China Clinical Oncology Next Generation Sequencing Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Clinical Oncology Next Generation Sequencing Market Segment Percentages, By Application, 2020 (%)
Hospitals
Clinics
Laboratories

Global Clinical Oncology Next Generation Sequencing Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Clinical Oncology Next Generation Sequencing Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Clinical Oncology Next Generation Sequencing Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Clinical Oncology Next Generation Sequencing Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Illumina, Inc.
Thermo Fisher Scientific
F. Hoffmann-La Roche Ltd.
Agilent Technologies
Myriad Genetics
Beijing Genomics Institute (BGI)
Perkin Elmer
Foundation Medicine
Pacific Bioscience
Oxford Nanopore Technologies Ltd.
Paradigm Diagnostics
Caris Life Sciences
Partek, Inc.
Eurofins Scientific S.E.
Qiagen N.V.